Insider Trading History of 667, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by 667, L.p. since 2012. The trader's CIK number is 1551139. At the time of the last reporting, 667, L.p. was the Director of Idera Pharmaceuticals, Inc.. (stock ticker symbol IDRA). Also see all insider trading activities at Idera Pharmaceuticals, Inc..

Note that in the past 667, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Genomic Health Inc (GHDX) by 667, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 GHDX 926,939 $25,373,860 0 $0 0 $0

Yearly summary of insider trading at Idera Pharmaceuticals, Inc. (IDRA) by 667, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 IDRA 3,250,000 $6,500,000 0 $0 0 $0

Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by 667, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 MRTX 425,000 $8,500,000 0 $0 0 $0


Insider trading activities at 3 companies by 667, L.p.:

1. Genomic Health Inc (GHDX)

2. Idera Pharmaceuticals, Inc. (IDRA)

3. Mirati Therapeutics, Inc. (MRTX)

Table 1. Insider trading of Genomic Health Inc (GHDX) by 667, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-11-13 GHDX Buy 103,839 27.99 2,906,661
2012-11-12 GHDX Buy 200,000 27.94 5,587,400
2012-11-09 GHDX Buy 519,933 27.05 14,061,587
2012-11-14 GHDX Buy 103,167 27.32 2,818,212

Table 2. Insider trading of Idera Pharmaceuticals, Inc. (IDRA) by 667, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-10-07 IDRA Buy 3,250,000 2.00 6,500,000

Table 3. Insider trading of Mirati Therapeutics, Inc. (MRTX) by 667, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-01-29 MRTX Buy 425,000 20.00 8,500,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by 667, L.p. (Director of Idera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.